Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Autophagic cell death of human pancreatic tumor cells mediated by oleandrin, a lipid-soluble cardiac glycoside.

Newman RA, Kondo Y, Yokoyama T, Dixon S, Cartwright C, Chan D, Johansen M, Yang P.

Integr Cancer Ther. 2007 Dec;6(4):354-64.

PMID:
18048883
2.

Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth.

Schoner W, Scheiner-Bobis G.

Am J Physiol Cell Physiol. 2007 Aug;293(2):C509-36. Epub 2007 May 9. Review.

3.

The role of apoptotic or nonapoptotic cell death in determining cellular response to anticancer treatment.

Kim R, Emi M, Tanabe K, Uchida Y, Arihiro K.

Eur J Surg Oncol. 2006 Apr;32(3):269-77. Epub 2006 Jan 23. Review.

PMID:
16431074
4.

Cardiac glycosides in cancer research and cancer therapy.

Winnicka K, Bielawski K, Bielawska A.

Acta Pol Pharm. 2006 Mar-Apr;63(2):109-15. Review.

5.

Autophagy and cancer therapy.

Kondo Y, Kondo S.

Autophagy. 2006 Apr-Jun;2(2):85-90. Epub 2006 Apr 29. Review.

PMID:
16874083
6.

Oleandrin: A cardiac glycosides with potent cytotoxicity.

Kumar A, De T, Mishra A, Mishra AK.

Pharmacogn Rev. 2013 Jul;7(14):131-9. doi: 10.4103/0973-7847.120512. Review. Retraction in: Pharmacogn Rev. 2016 Jul-Dec;10 (20):147.

7.

Inhibition of pancreatic cancer cell growth.

Adrian TE.

Cell Mol Life Sci. 2007 Oct;64(19-20):2512-21. Review.

PMID:
17676272
8.

Autophagy, bafilomycin and cell death: the "a-B-cs" of plecomacrolide-induced neuroprotection.

Shacka JJ, Klocke BJ, Roth KA.

Autophagy. 2006 Jul-Sep;2(3):228-30. Epub 2006 Jul 16. Review.

PMID:
16874105
9.

Autophagy: Molecular mechanisms and their implications for anticancer therapies.

Meschini S, Condello M, Lista P, Arancia G.

Curr Cancer Drug Targets. 2011 Mar;11(3):357-79. Review.

PMID:
21247381
10.

Assembling the puzzle of anti-cancer mechanisms triggered by cardiac glycosides.

Cerella C, Dicato M, Diederich M.

Mitochondrion. 2013 May;13(3):225-34. doi: 10.1016/j.mito.2012.06.003. Epub 2012 Jun 24. Review.

PMID:
22735572
11.

Digitoxin as an anticancer agent with selectivity for cancer cells: possible mechanisms involved.

López-Lázaro M.

Expert Opin Ther Targets. 2007 Aug;11(8):1043-53. Review.

PMID:
17665977
12.

Cell cycle inhibition in malignant lymphoma: disease control by attacking the cellular proliferation machinery.

Ringshausen I, Peschel C, Decker T.

Curr Drug Targets. 2006 Oct;7(10):1349-59. Review.

PMID:
17073597
13.

Oridonin: An active diterpenoid targeting cell cycle arrest, apoptotic and autophagic pathways for cancer therapeutics.

Li CY, Wang EQ, Cheng Y, Bao JK.

Int J Biochem Cell Biol. 2011 May;43(5):701-4. doi: 10.1016/j.biocel.2011.01.020. Epub 2011 Feb 2. Review.

PMID:
21295154
14.

Ex vivo programmed cell death and the prediction of response to chemotherapy.

Nagourney RA.

Curr Treat Options Oncol. 2006 Mar;7(2):103-10. Review.

PMID:
16455021
15.

Chemotherapy and autophagy-mediated cell death in pancreatic cancer cells.

Ropolo A, Bagnes CI, Molejon MI, Lo Re A, Boggio V, Gonzalez CD, Vaccaro MI.

Pancreatology. 2012 Jan-Feb;12(1):1-7. doi: 10.1016/j.pan.2011.11.003. Epub 2011 Nov 20. Review.

PMID:
22487466
16.

Cardiac glycosides in cancer therapy: from preclinical investigations towards clinical trials.

Slingerland M, Cerella C, Guchelaar HJ, Diederich M, Gelderblom H.

Invest New Drugs. 2013 Aug;31(4):1087-94. doi: 10.1007/s10637-013-9984-1. Epub 2013 Jun 10. Review.

PMID:
23748872
17.

Evaluating the cancer therapeutic potential of cardiac glycosides.

Calderón-Montaño JM, Burgos-Morón E, Orta ML, Maldonado-Navas D, García-Domínguez I, López-Lázaro M.

Biomed Res Int. 2014;2014:794930. doi: 10.1155/2014/794930. Epub 2014 May 8. Review.

18.

Cardenolides from the Apocynaceae family and their anticancer activity.

Wen S, Chen Y, Lu Y, Wang Y, Ding L, Jiang M.

Fitoterapia. 2016 Jul;112:74-84. doi: 10.1016/j.fitote.2016.04.023. Epub 2016 May 7. Review.

PMID:
27167183

Supplemental Content

Support Center